Funding Rounds
Grey Wolf Therapeutics

Grey Wolf Therapeutics Series B (2024, $50M)

Grey Wolf Therapeutics

Small molecules to increase tumor detection by the immune system.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $50.00M

Investors